Doctors could be penalized for ordering prostate tests Medicare officials are considering a measure that would penalize doctors who order routine prostate-cancer screening tests for their patients, as part of a federal effort to define and reward quality in health-care services.
Social and economic factors tied to pancreatic cancer surgery, survival Social and economic factors may influence who is most likely to get surgery for early-stage pancreas cancer, a new U.S. study suggests, and eliminating these gaps could improve outcomes, the authors say.
Pigeons tend to land on the right spot when looking for breast cancer - Years of schooling and training are needed to teach pathologists and radiologists to spot cancer on medical images, but a new study finds that pigeons can be about as accurate as these professionals, with the help of a few food pellets.
Many children with cancer were born at risk, study finds Gene sequencing of more than 1,000 children and adolescents diagnosed with cancer found that as many as 8.5 percent were born with genes that increase their risk of developing cancer, U.S. researchers said on Wednesday.
Servier and Pfizer get rights to Cellectis cancer cell therapy U.S. drugmaker Pfizer and France's Servier have snapped up rights to a promising cell therapy developed by French biotech firm Cellectis to fight blood cancers.
Price looms as major hurdle in hepatitis C eradication - New therapies can cure most cases of hepatitis C but lower drug prices, testing and better access to treatment are going to be needed to eliminate the liver-destroying virus worldwide, according to a New England Journal of Medicine editorial.
Baby's new leukemia treatment could help others with cancer A gene-editing technology that made headlines recently for successfully treating a baby with leukemia may one day be used to treat other types of cancers, experts say.
The 3 cancers doctors miss most, plus 4 other commonly misdiagnosed conditions Dizziness, sweating and nausea may sound like the flu, but those symptoms also could be signs of a heart attack.
Glowing terms often used for new cancer drugs in health news Health news stories often use overly optimistic terms to describe new cancer drugs, according to a new study.
